1
AGILE Research is a graphene based electronic binding assay that is an extension of recent advancements in the material science community. Protein binding kinetics measurements are increasingly common as tools allowing for effective binding measurements to gain wider adoption. However, use of these tools is often limited to concentrations and sample types outside of what is practical in a research environment. For example, many kinetic measurement techniques require an optically clear, homogeneous sample, leading to significant purification work and loss of material during sample processing. Electronic binding measurements represent a novel approach to obtain kinetics, which leverages advances in nanoelectronic sensors. In the past, electronic protein binding tools would require non-ionic diluents, severely limiting biological sample compatibility. We demonstrate that new commercially available tools using graphene sensors overcome this challenge. Data from AGILE Research demonstrates protein-protein binding kinetics measurements directly in complex media such as plasma and cell culture supernatant. AGILE (Automatic Graphene ImmunoLinked Electronic) directly connects electronics and biology Novel Protein Binding Kinetics Measurements in Complex Biological Samples using AGILE Brett Goldsmith, Amy Walker, Deng Pan, Mitch Lerner, Lauren Locascio, and Francie Barron. Nanomedical Diagnostics, San Diego, CA 92121 [email protected] SENSOR 1. Functionalize sensor with EDC and sulfo-NHS. Then apply capture molecule. 2. Block and quench with Quench 1 and Quench 2. 3. Apply background buffer and target analyte solution. Protocol Prefunctionalized Graphene Sensor 1. Functionalize (15 min) 2. Block & Quench (15 min) 3. Sense ( 2+ min) Rinse Cell Lysate Protein Extract Growth Media Tissue Lysate Unstable Target 100 ng/ml of crude cell lysate in 1X PBS with 1% BSA. Surface functionalized with monoclonal antibodies to bacteria target. 50 μg crude protein extract from cultured mammalian cells. 6 wells from a 12 well plate. Prepared with antibodies to target protein. 10 mg/mL beta- galactosidase in un- diluted cell growth media. Surface prepared with monoclonal antibody to beta-gal. 50 μg of protein from tissue lysate, each measurement from an individual embryo. Average (solid) and st. dev. (dotted). Detection of an unstable protein (lifetime ~ 15 minutes) in buffer. Surface functionalized with synthetic peptide. Our assay is a type of label free bioFET (biological field-effect- transistor). A current is run through the graphene and monitored. A potential varying between +/- 100 mV is applied to the liquid on top of the graphene. This varying potential changes the current through the graphene as in a field-effect-transistor. A capture molecule, such as an antibody or aptamer, is attached to the graphene surface. This capture molecule plays the role of “gate dielectric” found in a typical field effect transistor. The capture molecule attached to the graphene changes how the potential applied to the liquid effects the graphene. Changes in any exposed charge groups, or to the configuration of the capture molecule, alters the overall electrical properties of the circuit. The sensor chip above contains 40 graphene transistors in a single measurement “well.” Each of the transistors is functionalized with the same capture molecule. The sensitivity and specificity of the resulting bio-electronic device comes from the the attached capture molecule. Assay Description Sensing of 1 μg/mL bacteria lysate in undiluted blood plasma. Blue curves are from individual transistors on the chip surface. Black line is the average assay response. Undiluted Plasma Kinetics Letptin/anti-Leptin Standard Curve. Results Bacterial antibody Binding and Release measurement used to calculate k D The AGILE binding assay can be used in a wide variety of sample types from buffers to blood fractions A variety of targets and capture molecules can be used with the AGILE assay, including antibodies, peptides, and cells. Kinetic data can be gathered using this assay either through generation of a standard curve or through real time kinetics. Conclusion Abstract

Novel Protein Binding Kinetics Measurements in Complex Biological

Embed Size (px)

Citation preview

Page 1: Novel Protein Binding Kinetics Measurements in Complex Biological

AGILE Research is a graphene based electronic binding assay that is anextension of recent advancements in the material science community.Protein binding kinetics measurements are increasingly common as toolsallowing for effective binding measurements to gain wider adoption.However, use of these tools is often limited to concentrations andsample types outside of what is practical in a research environment. Forexample, many kinetic measurement techniques require an opticallyclear, homogeneous sample, leading to significant purification work andloss of material during sample processing. Electronic bindingmeasurements represent a novel approach to obtain kinetics, whichleverages advances in nanoelectronic sensors. In the past, electronicprotein binding tools would require non-ionic diluents, severely limitingbiological sample compatibility. We demonstrate that new commerciallyavailable tools using graphene sensors overcome this challenge. Datafrom AGILE Research demonstrates protein-protein binding kineticsmeasurements directly in complex media such as plasma and cell culturesupernatant.

AGILE (Automatic Graphene ImmunoLinked Electronic)

directly connects electronics and biology

Novel Protein Binding Kinetics Measurements in Complex Biological Samples using AGILE Brett Goldsmith, Amy Walker, Deng Pan, Mitch Lerner, Lauren Locascio, and Francie Barron.

Nanomedical Diagnostics, San Diego, CA 92121

[email protected]

SENSOR

1. Functionalize sensor with EDC and sulfo-NHS. Then apply capture molecule.

2. Block and quench with Quench 1 and Quench 2.

3. Apply background buffer and target analyte solution.

Protocol

PrefunctionalizedGraphene Sensor

1. Functionalize

(15 min)

2. Block & Quench

(15 min)

3. Sense

( 2+ min)

Rinse

Cell Lysate Protein Extract Growth Media Tissue Lysate Unstable Target

100 ng/ml of crude cell lysate in 1X PBS with 1% BSA. Surface functionalized with monoclonal antibodies to bacteria target.

50 µg crude protein extract from cultured mammalian cells. 6 wells from a 12 well plate. Prepared with antibodies to target protein.

10 mg/mL beta-galactosidase in un-diluted cell growth media. Surface prepared with monoclonal antibody to beta-gal.

50 µg of protein from tissue lysate, each measurement from an individual embryo. Average (solid) and st.dev. (dotted).

Detection of an unstable protein (lifetime ~ 15 minutes) in buffer. Surface functionalized with synthetic peptide.

Our assay is a type of label free bioFET (biological field-effect-transistor). A current is run through the graphene and monitored. Apotential varying between +/- 100 mV is applied to the liquid on top ofthe graphene. This varying potential changes the current through thegraphene as in a field-effect-transistor.A capture molecule, such as an antibody or aptamer, is attached to thegraphene surface. This capture molecule plays the role of “gatedielectric” found in a typical field effect transistor. The capturemolecule attached to the graphene changes how the potential appliedto the liquid effects the graphene. Changes in any exposed chargegroups, or to the configuration of the capture molecule, alters theoverall electrical properties of the circuit.The sensor chip above contains 40 graphene transistors in a singlemeasurement “well.” Each of the transistors is functionalized with thesame capture molecule. The sensitivity and specificity of the resultingbio-electronic device comes from the the attached capture molecule.

Assay Description

Sensing of 1 µg/mL bacteria lysate in undiluted blood plasma. Bluecurves are from individual transistors on the chip surface. Black line isthe average assay response.

Undiluted Plasma

Kinetics

Letptin/anti-LeptinStandard Curve.

Results

Bacterial antibody Binding and Release measurement used to calculate kD

• The AGILE binding assay can be used in a wide variety of sampletypes from buffers to blood fractions

• A variety of targets and capture molecules can be used with theAGILE assay, including antibodies, peptides, and cells.

• Kinetic data can be gathered using this assay either throughgeneration of a standard curve or through real time kinetics.

Conclusion

Abstract